The ABCs of ADCs: Ovarian Cancer and Antibody Drug Conjugates 

Register Here

Antibody-drug conjugates (ADCs) are an exciting addition to ovarian cancer treatment. New treatments for ovarian cancer bring hope, but they also raise questions for patients. In this conversation with Dr. Jill Alldredge, a gynecologic oncologist at UCHealth, we’ll discuss what an ADC is, the ins and outs of the first and only one currently approved for ovarian cancer, and any promising ADCs in the pipeline.

-Jill-AlldredgeDr. Jill Alldredge, a gynecologic oncologist at UCHealth


Register to get instructions to join.

Monday, 2:30-3pm ET
Sept 9

Register Here

National Helpline: